Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders
Clinical trial NCT01706523 · TERMINATED
Trial details
- NCT number
- NCT01706523
- Sponsor
- Seaside Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-07-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.